Retractable Technologies Inc Cash Flow Conversion Efficiency

Latest as of December 2025: -0.008x

Retractable Technologies Inc cash flow conversion efficiency. Based on the latest financial reports, Retractable Technologies Inc (RVP) has a cash flow conversion efficiency ratio of -0.008x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-596.54K) by net assets ($74.38 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Retractable Technologies Inc (2000–2025)

Cash flow conversion efficiency of Retractable Technologies Inc from 2000 to 2025. This chart illustrates how Retractable Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View RVP stock price for real-time trading data and today's change.

Retractable Technologies Inc Cash Flow Conversion Ratio Explained

Retractable Technologies Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Retractable Technologies Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Retractable Technologies Inc ranked by their cash flow conversion efficiency. Also see market cap of Retractable Technologies Inc for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Jiyuan Packaging Holdings Ltd
TW:8488
0.024x
Sun-Sea Construction
TWO:5516
-0.674x
Greenyield Bhd
KLSE:0136
-0.008x
Multi Hanna Kreasindo Tbk Pt
JK:MHKI
-0.176x
Astral Asia Bhd
KLSE:7054
0.003x
EL. D. Mouzakis S.A
AT:MOYZK
0.002x
Aarvi Encon Limited
NSE:AARVI
0.045x
EG Corporation
KQ:037370
0.034x

Annual Cash Flow Conversion Efficiency for Retractable Technologies Inc (2000–2025)

The table below shows the annual cash flow conversion efficiency of Retractable Technologies Inc from 2000 to 2025. Review Retractable Technologies Inc (RVP) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $74.38 Million $-7.06 Million -0.095x +28.36%
2024-12-31 $87.17 Million $-11.56 Million -0.133x -575.76%
2023-12-31 $99.29 Million $2.77 Million 0.028x -82.29%
2022-12-31 $106.54 Million $16.77 Million 0.157x -52.40%
2021-12-31 $99.17 Million $32.79 Million 0.331x -13.17%
2020-12-31 $49.88 Million $19.00 Million 0.381x +395.32%
2019-12-31 $28.54 Million $2.19 Million 0.077x +264.74%
2018-12-31 $25.61 Million $-1.20 Million -0.047x +56.60%
2017-12-31 $27.17 Million $-2.92 Million -0.108x -280.31%
2016-12-31 $28.11 Million $-794.91K -0.028x +73.02%
2015-12-31 $31.03 Million $-3.25 Million -0.105x +27.30%
2014-12-31 $26.83 Million $-3.87 Million -0.144x -242.03%
2013-12-31 $28.90 Million $2.93 Million 0.102x +2190.54%
2012-12-31 $35.73 Million $158.34K 0.004x -96.89%
2011-12-31 $38.65 Million $5.51 Million 0.143x -36.44%
2010-12-31 $38.90 Million $8.73 Million 0.224x +165.54%
2009-12-31 $35.92 Million $-12.30 Million -0.342x -143.99%
2008-12-31 $42.21 Million $-5.92 Million -0.140x -72.27%
2007-12-31 $51.76 Million $-4.22 Million -0.081x -45.03%
2006-12-31 $59.71 Million $-3.35 Million -0.056x -58.93%
2005-12-31 $63.24 Million $-2.23 Million -0.035x -103.98%
2004-12-31 $63.66 Million $56.48 Million 0.887x +66.62%
2003-12-31 $15.13 Million $8.06 Million 0.532x +356.54%
2002-12-31 $7.44 Million $-1.54 Million -0.208x +99.08%
2001-12-31 $162.62K $-3.67 Million -22.585x -1909.72%
2000-12-31 $7.37 Million $-8.28 Million -1.124x --

About Retractable Technologies Inc

NYSE MKT:RVP USA Medical Instruments & Supplies
Market Cap
$21.26 Million
Market Cap Rank
#24832 Global
#5299 in USA
Share Price
$0.71
Change (1 day)
+5.01%
52-Week Range
$0.62 - $0.88
All Time High
$21.50
About

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allerg… Read more